Contributors |
|
ix | |
|
1 Cereals and pulses - an overview |
|
|
1 | (6) |
|
|
1 | (1) |
|
1.2 Chemistry and nutraceutical compositions |
|
|
2 | (1) |
|
1.3 Potential health beneficial effects |
|
|
2 | (5) |
|
|
5 | (2) |
|
2 Effects of barley consumption on cardiovascular and diabetic risk |
|
|
7 | (14) |
|
|
7 | (1) |
|
2.2 Barley β-glucan and risk of cardiovascular diseases, diabetes and colon carcinogenesis |
|
|
7 | (4) |
|
2.3 Other nutraceutical components and properties in barley |
|
|
11 | (4) |
|
2.4 Potential of hulless barley in health promotion and disease prevention |
|
|
15 | (1) |
|
|
15 | (6) |
|
|
16 | (5) |
|
3 Nutraceutical properties and health benefits of oats |
|
|
21 | (16) |
|
|
21 | (1) |
|
3.2 Oat grain composition |
|
|
22 | (1) |
|
3.3 The chemical and physical property of oat β-glucan |
|
|
23 | (2) |
|
3.4 Effects of processing on oat β-glucan |
|
|
25 | (1) |
|
|
26 | (5) |
|
|
31 | (6) |
|
|
31 | (6) |
|
4 Nutraceutical properties and health benefits of rice |
|
|
37 | (28) |
|
|
37 | (1) |
|
4.2 Rice grain structure and nutritional composition distribution |
|
|
38 | (2) |
|
4.3 Nutrient compositions and their health benefits |
|
|
40 | (13) |
|
4.4 Biofortification of nutrients in rice grain to improve its health benefits |
|
|
53 | (1) |
|
4.5 Health benefits of rice bran |
|
|
54 | (1) |
|
4.6 Health benefits of whole rice grain consumption |
|
|
55 | (2) |
|
|
57 | (8) |
|
|
57 | (8) |
|
5 Hypolipedemic effects of rice bran oil |
|
|
65 | (6) |
|
|
65 | (1) |
|
5.2 Chemical composition of rice bran oil (RBO) |
|
|
65 | (1) |
|
5.3 Hypolipidemic effect of rice bran oil |
|
|
66 | (2) |
|
5.4 Other beneficial effects of rice bran oil |
|
|
68 | (1) |
|
|
69 | (2) |
|
|
70 | (1) |
|
6 Phenolic phytochemicals from rye (Secale Cereale L.) |
|
|
71 | (14) |
|
|
71 | (1) |
|
6.2 Three classes of the phenolic compounds |
|
|
72 | (1) |
|
6.3 Extraction methodology |
|
|
72 | (8) |
|
|
80 | (1) |
|
|
81 | (1) |
|
6.6 Health beneficial effects of rye intake |
|
|
82 | (1) |
|
|
82 | (3) |
|
|
82 | (3) |
|
7 Bioactive compounds in corn |
|
|
85 | (20) |
|
|
85 | (1) |
|
7.2 Phytochemicals in corn and their health benefits |
|
|
85 | (11) |
|
7.3 Corn resistant starch and bioactivities |
|
|
96 | (1) |
|
|
97 | (8) |
|
|
98 | (7) |
|
8 Nutraceutical and health properties of adlay |
|
|
105 | (8) |
|
|
105 | (1) |
|
8.2 Health components of adlay |
|
|
105 | (2) |
|
8.3 Potential health beneficial properties |
|
|
107 | (4) |
|
|
111 | (2) |
|
|
111 | (2) |
|
9 Antioxidant and health promoting properties of wheat (Triticum spp.) |
|
|
113 | (18) |
|
|
113 | (1) |
|
9.2 Evidence of wheat's health promoting properties |
|
|
113 | (1) |
|
9.3 The antioxidant contents of wheat |
|
|
114 | (3) |
|
9.4 Reported antioxidant and other health promoting properties of wheat |
|
|
117 | (2) |
|
9.5 Bioavailability of phenolic acids in wheat |
|
|
119 | (1) |
|
9.6 Use of post-harvest treatments to improve the bioaccessabilty of antioxidant in wheat-based ingredients |
|
|
120 | (3) |
|
9.7 Effects of processing on antioxidants in wheat-based food systems |
|
|
123 | (8) |
|
|
126 | (5) |
|
10 Buckwheat: A novel pseudocereal |
|
|
131 | (18) |
|
10.1 Introduction of buckwheat |
|
|
131 | (2) |
|
10.2 Nutritional composition of buckwheat |
|
|
133 | (3) |
|
10.3 Unique health components of buckwheat |
|
|
136 | (8) |
|
10.4 Allergens in buckwheat |
|
|
144 | (1) |
|
10.5 Research trends of buckwheat nutritional and functional properties |
|
|
145 | (4) |
|
|
146 | (3) |
|
11 Nutraceutical and health properties of psyllium |
|
|
149 | (16) |
|
|
149 | (1) |
|
11.2 Health beneficial effects of psyllium |
|
|
150 | (8) |
|
11.3 Potential in controlled delivery of bioactives |
|
|
158 | (1) |
|
11.4 Possible adverse effects |
|
|
159 | (6) |
|
|
160 | (5) |
|
12 Nutraceutical and health properties of sorghum and millet |
|
|
165 | (22) |
|
|
165 | (2) |
|
12.2 Phytochemicals in sorghum and millet grains and fractions |
|
|
167 | (6) |
|
12.3 Antioxidant properties of sorghum and millet grain and components |
|
|
173 | (3) |
|
12.4 Potential beneficial effects of sorghum and millet consumption in human health |
|
|
176 | (6) |
|
|
182 | (5) |
|
|
182 | (5) |
|
13 Nutraceutical and health properties of common beans (Phaseolus vulgaris) |
|
|
187 | (12) |
|
|
187 | (1) |
|
13.2 Health beneficial effects of Phaseolus vulgaris |
|
|
187 | (7) |
|
13.3 Possible adverse effects |
|
|
194 | (1) |
|
|
194 | (5) |
|
|
194 | (5) |
|
14 Health benefits and bioactive compounds in field peas, faba beans, and chickpeas |
|
|
199 | (18) |
|
|
199 | (1) |
|
14.2 Phenolic compounds in field peas, chickpeas, and faba beans |
|
|
200 | (2) |
|
14.3 Health benefits of compounds in field peas, chickpeas, and faba beans |
|
|
202 | (7) |
|
14.4 Antinutritional factors in peas, chickpeas, and faba beans |
|
|
209 | (1) |
|
|
210 | (7) |
|
|
212 | (5) |
|
15 Bioactives and health benefits of lentils (Lens culinaris L.) |
|
|
217 | (12) |
|
|
217 | (1) |
|
15.2 Epidemiology: pulses and chronic diseases |
|
|
217 | (4) |
|
15.3 Health effects of pulse carbohydrates |
|
|
221 | (1) |
|
15.4 Health promoting vitamins and minerals in lentils |
|
|
222 | (1) |
|
15.5 Health promoting phenolic compounds in lentils |
|
|
222 | (7) |
|
|
225 | (4) |
|
16 Soy isoflavones and bone health |
|
|
229 | (14) |
|
|
229 | (1) |
|
16.2 Biosynthesis and composition of isoflavones in soybeans |
|
|
230 | (1) |
|
16.3 Separation, characterization, and analysis of isoflavones |
|
|
231 | (1) |
|
16.4 Soy isoflavones and bone health |
|
|
232 | (5) |
|
|
237 | (6) |
|
|
238 | (5) |
|
17 Effects of dietary soy on the prevention of cardiovascular disease |
|
|
243 | (18) |
|
|
243 | (1) |
|
17.2 Soy foods and serum cholesterol |
|
|
243 | (6) |
|
17.3 Soy and inhibition of LDL oxidation |
|
|
249 | (3) |
|
17.4 Soy and inflammation |
|
|
252 | (1) |
|
17.5 Soy and hypertension |
|
|
252 | (1) |
|
17.6 Soy and endothelial function |
|
|
253 | (1) |
|
|
253 | (8) |
|
|
254 | (7) |
|
18 Dietary fiber and human health |
|
|
261 | (12) |
|
|
261 | (1) |
|
18.2 Dietary fiber and metabolic syndrome |
|
|
261 | (3) |
|
18.3 Dietary fiber and cancer |
|
|
264 | (3) |
|
18.4 Dietary fiber and cardiovascular diseases |
|
|
267 | (1) |
|
18.5 Potential undesirable effects |
|
|
268 | (1) |
|
|
269 | (4) |
|
|
269 | (4) |
|
19 Antioxidants and human health |
|
|
273 | (36) |
|
|
273 | (1) |
|
19.2 Anti-inflammatory capacity of antioxidants |
|
|
274 | (4) |
|
19.3 Antioxidants and metabolic syndrome |
|
|
278 | (7) |
|
19.4 Antioxidants and cancer |
|
|
285 | (5) |
|
19.5 Antioxidants and cardiovascular diseases |
|
|
290 | (5) |
|
19.6 Summary and conclusions |
|
|
295 | (14) |
|
|
295 | (14) |
Index |
|
309 | |